P C Genufix Orthopedics is categorized under Orthopedic Doctors and Physicians in Syracuse, NY and active since 2010.
P C Genufix Orthopedics was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Daniel Wnorowski at the company’s single location by writing to 475 Irving Avenue # 418, Syracuse, New York NY 13210 or by phoning (315) 426-0190. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | P C Genufix Orthopedics |
Contact Person: | Daniel Wnorowski |
Address: | 475 Irving Avenue # 418, Syracuse, New York 13210 |
Phone Number: | (315) 426-0190 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
P C Genufix Orthopedics was started in 2010 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Daniel Wnorowski for inquiries that concern P C Genufix Orthopedics by calling the company number (315) 426-0190, as your correspondence is most welcome. Additionally, the physical location of the single location of P C Genufix Orthopedics can be found at the coordinates 43.045768,-76.137582 as well as the street address 475 Irving Avenue # 418 in Syracuse, New York 13210.
For its online presence, you may visit P C Genufix Orthopedics’s website at and engage with its social media outlets through on Twitter and on Facebook.